THE RELATIONSHIP BETWEEN SERUM OSTEOPROTEGERIN LEVELS AND CLINICAL, PARACLINICAL CHARACTERISTICS IN PATIENTS WITH ACUTE MYOCARDIAL INFARCTION
Main Article Content
Abstract
Objectives: To investigate the relationship between serum OPG levels and clinical, paraclinical characteristics in patients with acute myocardial infarction (AMI). Methods: We enrolled 135 acute MI patients underwent percutaneous coronary intervention at Cardiovascular Intervention Department – 103 Military Hospital from 02/2021 to 04/2023 and 50 control subjects without coronary artery disease. Testing serum OPG levels at the time of admission, evaluating the relationship between OPG levels and clinical, paraclinical characteristics. Result: OPG concentration in patients with AMI was significantly higher than that in the control group (2323.63 ± 2276.23 pg/ml vs. 1424.24 ± 456.74 pg/ml, p < 0,001). In the MI group, patients admitted early (≤ 12h) had signficantly lower OPG concentrations than patients admitted late (> 12h); levels of serum OPG had a strong positive correlation with age (r = 0.527, p < 0.001), a moderate positive correlation with Troponin I (r = 0,346, p < 0.001), CK – MB (r = 0,323, p < 0.001) and NT-proBNP (r = 0.337, p < 0.001). Patients with multivessel coronary artery lesions had significantly higher OPG levels than those with single vessel lesions (2450.37 ± 696.99 vs 2127.53 ± 664.49 pg/ml, p < 0.05). Conclusion: Patients admitted early (≤ 12h) had signficantly lower OPG concentrations than patients admitted late (> 12h). Levels of serum OPG had a positive correlation with age, Troponin I, CK-MB and NT-proBNP. Patients with multivessel coronary artery lesions had significantly higher OPG levels than those with single vessel lesions.
Article Details
Keywords
Acute myocardial infarction, Osteoprotegerin.
References
2. Crisafulli, A., et al., Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction. Clin Sci (Lond), 2005. 109(4): p. 389-95.
3. Roysland, R., et al., Osteoprotegerin and cardiovascular mortality in patients with non-ST elevation acute coronary syndromes. Heart, 2012. 98(10): p. 786-91.
4. Thygesen, K., et al., Fourth Universal Definition of Myocardial Infarction (2018). Circulation, 2018. 138(20): p. e618-e651.
5. Hosbond, S.E., et al., Can osteoprotegerin be used to identify the presence and severity of coronary artery disease in different clinical settings? Atherosclerosis, 2014. 236(2): p. 230-6.
6. Omland, T., et al., Plasma osteoprotegerin levels in the general population: relation to indices of left ventricular structure and function. Hypertension, 2007. 49(6): p. 1392-8.
7. Cottin, Y., et al., Association between Serum Osteoprotegerin Levels and Severity of Coronary Artery Disease in Patients with Acute Myocardial Infarction. J Clin Med, 2021. 10(19).
8. Jono, S., et al., Serum osteoprotegerin levels are associated with the presence and severity of coronary artery disease. Circulation, 2002. 106(10): p. 1192-4.